EAR-20 peptide, a novel NMDA receptor positive allosteric modulator

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Allosteric modulators fine-tune ligand-gated ion channel activity without competing with endogenous ligands.
• NMDA receptors (NMDARs) are crucial for neurotransmission and synaptic plasticity, making them therapeutic targets for NMDAR hypofunction disorders.

Purpose of the Study:

• To characterize EAR-20, a peptide from Conantokin-G, as a novel positive allosteric modulator (PAM) of NMDARs.
• To investigate the mechanism of EAR-20 action and its therapeutic potential for NMDAR-related disorders.

Main Methods:

• Molecular docking to identify binding sites.
• Whole-cell and single-channel patch-clamp electrophysiology.
• Recordings in cultured hippocampal neurons to assess NMDAR function.

Main Results:

• EAR-20 enhances NMDAR function by increasing channel open probability and reducing desensitization.
• It potentiates GluN1-GluN2A and GluN1-GluN2B receptors significantly and enhances NMDAR currents in neurons.
• Molecular docking revealed a binding site at the GluN1-GluN2B interface, with Ser773 in GluN1 being critical.
• EAR-20 partially rescued NMDARs with loss-of-function mutations.

Conclusions:

• EAR-20 is a novel, subunit-dependent positive allosteric modulator of NMDARs.
• It demonstrates potential for developing therapeutics targeting NMDAR hypofunction in neurological and neurodevelopmental disorders.